pd 153035 has been researched along with troglitazone in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H | 1 |
| Diggle, C; Holder, J; Lee, WC; Selby, PJ; Southgate, J; Stahlschmidt, J; Trejdosiewicz, LK; Varley, CL | 1 |
| Smith, B; Southgate, J; Stahlschmidt, J; Stower, M; Varley, CL | 1 |
| Aoi, T; Fujisawa, M; Hinata, N; Koyanagi-Aoi, M; Suzuki, K; Uehara, K | 1 |
| Bergum, N; Garrett, SH; Knutson, P; Mehus, AA; Sens, DA; Sens, MA; Shrestha, S; Somji, S; Zhou, XD | 1 |
5 other study(ies) available for pd 153035 and troglitazone
| Article | Year |
|---|---|
Identifying off-target effects and hidden phenotypes of drugs in human cells.
Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship | 2006 |
Role of PPARgamma and EGFR signalling in the urothelial terminal differentiation programme.
Topics: Active Transport, Cell Nucleus; Adipocytes; Anilides; Animals; Blotting, Western; Cattle; Cell Differentiation; Cell Line; Cell Proliferation; Chromans; Enzyme Inhibitors; Epidermal Growth Factor; Epithelium; ErbB Receptors; Gene Expression Regulation; Humans; Immunoprecipitation; Ligands; Membrane Glycoproteins; Membrane Proteins; Microscopy, Fluorescence; Phosphorylation; PPAR gamma; Promoter Regions, Genetic; Quinazolines; Ribonucleases; RNA, Messenger; Signal Transduction; Thiazolidinediones; Time Factors; Troglitazone; Uroplakin Ia; Uroplakin Ib; Uroplakin II; Uroplakin III; Urothelium | 2004 |
Activation of peroxisome proliferator-activated receptor-gamma reverses squamous metaplasia and induces transitional differentiation in normal human urothelial cells.
Topics: Cell Differentiation; Chromans; Cloning, Molecular; DNA, Complementary; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Humans; Immunoblotting; Immunohistochemistry; Keratins; Metaplasia; Microscopy, Fluorescence; Quinazolines; Receptors, Cytoplasmic and Nuclear; Ribonucleases; RNA, Messenger; Signal Transduction; Thiazolidinediones; Transcription Factors; Troglitazone; Urothelium | 2004 |
Directed differentiation of human induced pluripotent stem cells into mature stratified bladder urothelium.
Topics: CDX2 Transcription Factor; Cell Differentiation; Cells, Cultured; Dextrans; Endoderm; ErbB Receptors; Fibroblast Growth Factor 10; Fluorescein-5-isothiocyanate; Glycogen Synthase Kinase 3 beta; Humans; Induced Pluripotent Stem Cells; Permeability; PPAR gamma; Pyridines; Pyrimidines; Quinazolines; Recombinant Proteins; Regenerative Medicine; SOXF Transcription Factors; Troglitazone; Urinary Bladder; Uroplakins; Urothelium | 2019 |
Activation of PPARĪ³ and inhibition of cell proliferation reduces key proteins associated with the basal subtype of bladder cancer in As3+-transformed UROtsa cells.
Topics: Animals; Arsenites; Biomarkers, Tumor; Cell Line, Tumor; Cell Proliferation; Down-Regulation; ErbB Receptors; Hepatocyte Nuclear Factor 3-alpha; Humans; Keratins; Mice; Mice, Nude; PPAR gamma; Quinazolines; Transcription Factors; Transcriptome; Transplantation, Heterologous; Troglitazone; Up-Regulation; Urinary Bladder Neoplasms | 2020 |